Carcinome épidermoïde cutané
Author:
- 12 November 2025
- journal article
- review article
- Published by Elsevier in Annales de Chirurgie Plastique Esthétique
- Vol. 70 (6) , 457-460
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023European Journal of Cancer, 2023
- European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023European Journal of Cancer, 2023
- Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell CarcinomaNew England Journal of Medicine, 2022
- Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell CarcinomasJournal of Clinical Oncology, 2020
- Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)Journal of Clinical Oncology, 2020
- PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell CarcinomaNew England Journal of Medicine, 2018
- Cutaneous squamous cell carcinomaJournal of the American Academy of Dermatology, 2018
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenGenome Medicine, 2017
- Carcinome épidermoïde cutané (carcinome spinocellulaire) : Recommandations de pratique clinique pour la prise en charge diagnostique et thérapeutique Argumentaire - Mai 2009Annales de Dermatologie et de Vénéréologie, 2009
- Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantationJournal of the American Academy of Dermatology, 1995